FT Health: Future of AntibioticsThe FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chainFT Health: Cell TherapiesResearch breakthroughs are accelerating cell therapy’s progress out of the lab and into the clinic. In this report we look at some of its most promising applications — including in the fight against Covid-19 — and examine the obstacles it still facesFT Health: Combating CoronavirusAs researchers race to develop a coronavirus vaccine, we look at efforts to ensure that the world’s poor are not left behind — and ask whether the pandemic will jolt policymakers into confronting the looming threat from antimicrobial resistanceFT Health: Combating MalariaHow the fight against coronavirus could set back malaria progress by 20 years; lockdown and drug ‘hijack’ fears in India; a childhood malaria sufferer turned scientist on why Africa needs treatments that fitFT Health: Combating DiabetesOver 460m people worldwide have diabetes, a figure that is projected to reach 700m by 2045. This report looks at the factors behind this rise, the latest high-tech solutions, and how health services are coping — or failing toFT Health: Regenerative MedicineRapid advances in technology from bioelectronics to gene therapy offer new ways to treat many illnesses. But medical breakthroughs bring with them new questions of pricing, access and scientific responsibilityMore from this Special ReportUniversal HealthcareWorld leaders have committed to introduce universal health coverage by 2030 as part of the UN’s Sustainable Development Goals. FT writers discuss the policies and innovations in technology that could help bring this aboutFT Health: Business and DementiaHow can business do more to accommodate workers with a dementia diagnosis? Also: researchers seek ways to tackle problems of underdiagnosis; tech leads the charge to protect people’s independenceFT Health: Dementia CareWhile there is still no sign of a cure for the 50m people around the world living with dementia, new technologies and imaginative public policies are helping lessen some of the burden. FT writers examine the latest developmentsFT Health: Future of Research & DevelopmentFrom genome-editing and digital surgery to the make-up of clinical trials and Cambridge’s future as a UK research hub, FT writers look at the latest developments in health R&DFT Health: Combating CancerHave blunt instrument drugs like chemotherapy had their day? Plus: genetic research makes personalised treatments a reality, the push to immunotherapy, apps that extend lives, the scourge of western lifestyles and the ‘toxicity’ of cancer drugs’ costFT Health: Combating DementiaEfforts to find a treatment or cure are intensifying as more drugs flunk trials. We also look at dementia’s growing financial burden, China’s big potential care market, and why some scientists are turning to Ayurvedic medicineFT Health: The Future of Rare DiseasesThere are few treatment options for orphan conditions, which affect only small numbers of patients. But scientists are zeroing in on particular genes to develop therapies that may give some hopeFT Health: Access to HealthcareGrowing and ageing populations around the world are creating stronger demand for healthcare. Yet limited money and out of date infrastructure mean policymakers in rich and poor countries alike are faced with the challenge of making sure their citizens have access to the resources they needFT Health: VaccinesVaccine research grows vigorously, propelled by rising world demand to fight existing diseases and to guard against new threats.FT Health: G20Angela Merkel puts health at the centre of the G20 agenda; antimicrobial resistance poses a threat to the global economy; South Africa reaches a crunch point in its fight against HIV; and why wellness is moving into the workplace
FT Health: Future of AntibioticsThe FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chainFT Health: Cell TherapiesResearch breakthroughs are accelerating cell therapy’s progress out of the lab and into the clinic. In this report we look at some of its most promising applications — including in the fight against Covid-19 — and examine the obstacles it still facesFT Health: Combating CoronavirusAs researchers race to develop a coronavirus vaccine, we look at efforts to ensure that the world’s poor are not left behind — and ask whether the pandemic will jolt policymakers into confronting the looming threat from antimicrobial resistanceFT Health: Combating MalariaHow the fight against coronavirus could set back malaria progress by 20 years; lockdown and drug ‘hijack’ fears in India; a childhood malaria sufferer turned scientist on why Africa needs treatments that fitFT Health: Combating DiabetesOver 460m people worldwide have diabetes, a figure that is projected to reach 700m by 2045. This report looks at the factors behind this rise, the latest high-tech solutions, and how health services are coping — or failing toFT Health: Regenerative MedicineRapid advances in technology from bioelectronics to gene therapy offer new ways to treat many illnesses. But medical breakthroughs bring with them new questions of pricing, access and scientific responsibilityMore from this Special ReportUniversal HealthcareWorld leaders have committed to introduce universal health coverage by 2030 as part of the UN’s Sustainable Development Goals. FT writers discuss the policies and innovations in technology that could help bring this aboutFT Health: Business and DementiaHow can business do more to accommodate workers with a dementia diagnosis? Also: researchers seek ways to tackle problems of underdiagnosis; tech leads the charge to protect people’s independenceFT Health: Dementia CareWhile there is still no sign of a cure for the 50m people around the world living with dementia, new technologies and imaginative public policies are helping lessen some of the burden. FT writers examine the latest developmentsFT Health: Future of Research & DevelopmentFrom genome-editing and digital surgery to the make-up of clinical trials and Cambridge’s future as a UK research hub, FT writers look at the latest developments in health R&DFT Health: Combating CancerHave blunt instrument drugs like chemotherapy had their day? Plus: genetic research makes personalised treatments a reality, the push to immunotherapy, apps that extend lives, the scourge of western lifestyles and the ‘toxicity’ of cancer drugs’ costFT Health: Combating DementiaEfforts to find a treatment or cure are intensifying as more drugs flunk trials. We also look at dementia’s growing financial burden, China’s big potential care market, and why some scientists are turning to Ayurvedic medicineFT Health: The Future of Rare DiseasesThere are few treatment options for orphan conditions, which affect only small numbers of patients. But scientists are zeroing in on particular genes to develop therapies that may give some hopeFT Health: Access to HealthcareGrowing and ageing populations around the world are creating stronger demand for healthcare. Yet limited money and out of date infrastructure mean policymakers in rich and poor countries alike are faced with the challenge of making sure their citizens have access to the resources they needFT Health: VaccinesVaccine research grows vigorously, propelled by rising world demand to fight existing diseases and to guard against new threats.FT Health: G20Angela Merkel puts health at the centre of the G20 agenda; antimicrobial resistance poses a threat to the global economy; South Africa reaches a crunch point in its fight against HIV; and why wellness is moving into the workplace
